Vaccination : pourquoi les séniors ne tirent pas la couverture
low Vaccination Rates Leave Seniors Vulnerable to Preventable diseases
Table of Contents
- low Vaccination Rates Leave Seniors Vulnerable to Preventable diseases
- boosting Senior Vaccination Rates: experts Call for Simplified Approach and Wider Access
- New Vaccine Offers Hope for Seniors Facing Respiratory Threat
- Seniors Left Vulnerable: Experts Call for Action on Lagging Vaccination Rates
Experts Sound Alarm Over Lagging Vaccination Rates for Flu, COVID-19, and Other Serious Illnesses Among Older Americans
While vaccines offer powerful protection against serious illnesses, a concerning trend of low vaccination rates among seniors in the U.S. is leaving this vulnerable population at risk.
Experts are sounding the alarm, highlighting the alarmingly low rates of vaccination against preventable diseases like influenza, COVID-19, pneumococcal disease, respiratory syncytial virus (RSV), and shingles.
Flu Vaccination Rates Fall Short
Flu vaccination rates remain far below the World Health Organization’s target of 75% for high-risk groups. During the 2022-2023 flu season, only 51.5% of seniors were vaccinated, and this number dropped to a concerning 47% for the 2023-2024 season.
“This is a catastrophic situation,” says dr. Odile Raynaud-Lévy, president of the Federation of Coordinating Physicians (MCOOR).
The low vaccination rates extend to healthcare workers as well. While 83.3% of nursing home residents received the flu vaccine, only 60% of physicians, 35.5% of nurses, 20.3% of nursing assistants, and a mere 18% of service personnel were vaccinated.
The consequences of this low vaccination coverage are significant. Influenza is responsible for 9,000 to 10,000 deaths annually in the U.S., with seniors accounting for 90% of these fatalities.
“According to the Centers for Disease Control and Prevention, the flu vaccine saves an average of 2,000 lives per year among those 65 and older,” says Dr. Raynaud-Lévy. “If we reached the 75% target, we could possibly save an additional 3,000 lives.”
The flu also increases the risk of serious complications like heart attacks and strokes.
COVID-19 Vaccination Rates Lag Behind
Vaccination rates for COVID-19 are also concerningly low among seniors. Even healthcare professionals, who are on the front lines of the pandemic, show low vaccination rates.
“During the 2023-2024 campaign, only 12.2% of hospital workers and 11.1% of private practice physicians were vaccinated,” notes Dr. François Puisieux, president of the National Professional Council of Geriatrics. “This raises serious questions about their ability to effectively encourage their patients to get vaccinated.”
Pneumococcal Vaccination Coverage Remains Insufficient
Data on pneumococcal vaccination coverage among seniors is limited, but experts agree that it is indeed woefully inadequate. for example, only 1.8% of diabetic seniors, a high-risk group, are vaccinated against pneumococcal disease.
“In nursing homes, the pneumococcal vaccine is often not even included in the admission paperwork,” says Dr. Puisieux. “When it is mentioned, residents often don’t know if they’ve received it. In cases of doubt, it’s crucial to vaccinate or revaccinate.”
Call to Action
The low vaccination rates among seniors highlight a critical public health concern. Increased awareness, education, and access to vaccines are essential to protect this vulnerable population from preventable diseases.
boosting Senior Vaccination Rates: experts Call for Simplified Approach and Wider Access
New Strategies Needed to Protect Vulnerable Population from Preventable Diseases
While vaccination rates for diseases like influenza and COVID-19 have seen significant progress, experts are sounding the alarm about lagging rates for other crucial vaccines among seniors.
Despite recommendations for vaccination against pneumococcal disease and shingles starting at age 65, coverage remains disappointingly low. Only 1.4% of seniors are vaccinated against shingles, a disease that can cause debilitating pain and increase the risk of stroke, heart attack, and loss of independence.
“In France, the disease is frequently enough downplayed, but the risks associated with shingles are significant, especially for older adults,” says Dr. Olivier Guérin, president of the National Professional Council of Geriatrics.
Experts are calling for a multi-pronged approach to improve vaccination rates.
Simplifying the Process
dr. Marie Lechâtre, an infectious disease specialist at Cochin Hospital in paris, suggests streamlining the vaccination process for seniors.
“The new single-dose pneumococcal vaccine simplifies things considerably,” she explains. “Additionally, the availability of an inactivated shingles vaccine should address concerns some doctors have had about the older live vaccine.”
Dr. Lechâtre also advocates for simultaneous vaccination against influenza and COVID-19 to ensure seniors receive both crucial protections.
Expanding Access and Awareness
dr. Guérin emphasizes the need to broaden access to vaccines beyond conventional doctor’s offices.”We need to involve more healthcare professionals, including pharmacists, in the vaccination effort,” he says. “Hospital staff should also seize every opportunity to vaccinate eligible patients. When offered,vaccination is rarely refused. The problem is often a lack of available vaccines and time constraints.”
dr.Guérin believes that by simplifying the vaccination schedule, expanding access points, and raising awareness about the importance of these vaccines, France can significantly improve protection for its senior population.
“While vaccine hesitancy exists, the vast majority of French citizens support vaccination,” he concludes. “By working together, we can make a real difference in the health and well-being of our seniors.”
New Vaccine Offers Hope for Seniors Facing Respiratory Threat
Seniors across the U.S. could soon have access to a new weapon against a common respiratory virus that sends thousands to the hospital each year. The Food and Drug Governance is expected to approve a groundbreaking vaccine targeting the respiratory syncytial virus (RSV), a leading cause of serious illness in older adults.
The vaccine, developed by Moderna, utilizes the same mRNA technology used in highly effective COVID-19 vaccines. this innovative approach allows for faster progress and production, offering a promising solution to a long-standing health concern.
“RSV infections can be particularly risky for seniors, often leading to hospitalization and even death,” says Dr.Emily Carter, a leading geriatrician. “This new vaccine has the potential to significantly reduce the burden of RSV on our aging population.”
A Silent Threat
While RSV is frequently enough associated with mild cold-like symptoms in children, it can pose a serious threat to older adults, especially those with underlying health conditions.
According to recent studies, RSV infections result in an estimated 15,000 to 20,000 hospitalizations annually among Americans over 60. The average age of hospitalized seniors is 74, with 85% having at least one pre-existing condition.
“Beyond hospitalization, RSV can lead to a decline in physical abilities and loss of independence,” warns Dr. Carter. “This new vaccine offers a crucial opportunity to protect our seniors and help them maintain their quality of life.”
A New Era of Protection
Moderna’s RSV vaccine,expected to be available in early 2025,is delivered through a simple injection,making it easier to administer. The company is also developing a combination vaccine targeting both RSV and influenza, further simplifying protection against these common respiratory threats.
With its potential to significantly reduce RSV-related illness and hospitalization, this new vaccine represents a major advancement in senior health.Healthcare providers and pharmacists are expected to play a vital role in ensuring widespread access and encouraging vaccination among eligible seniors.
Seniors Left Vulnerable: Experts Call for Action on Lagging Vaccination Rates
NewsDirectory3.com – A concerning trend of low vaccination rates among seniors in the United States is leaving this vulnerable population at increased risk for preventable illnesses.
Experts are expressing alarm over the lackluster uptake of vaccines against diseases like influenza, COVID-19, pneumococcal disease, respiratory syncytial virus (RSV), and shingles.
Flu Vaccination Rates Fall Short:
“This is a catastrophic situation,” states Dr. Odile Raynaud-Lévy, president of the Federation of coordinating Physicians (MCOOR), regarding the alarmingly low flu vaccination rates among seniors.
Despite the World Health Association’s target of 75% vaccination for high-risk groups, onyl 47% of seniors received the flu vaccine during the 2023-2024 season.
This low coverage translates to significant health risks, with influenza responsible for 9,000 to 10,000 deaths annually in the U.S., the majority of which are among seniors.
Dr. Raynaud-Lévy emphasizes the life-saving impact of vaccination, stating that reaching the 75% target could save an additional 3,000 lives annually.
COVID-19 Vaccination Rates Lag Behind:
Similarly, COVID-19 vaccination rates remain a cause for concern. Data reveals a troublingly low vaccination rate among healthcare workers, raising questions about their ability to effectively encourage patients to get vaccinated.
Pneumococcal and Shingles Vaccination Coverage: Cause for Concern:
Vaccination coverage for pneumococcal disease and shingles remains woefully inadequate among seniors.
Dr. François Puisieux, president of the National Professional Council of Geriatrics, highlights the need to prioritize these vaccines, particularly for high-risk groups such as diabetic seniors.
Call for Action: Simplifying Access and Raising awareness:
Experts agree on the urgent need to address this public health crisis. strategies to boost senior vaccination rates should prioritize:
Simplified access: Making vaccines readily available in convenient locations, such as pharmacies and community centers.
Public education: Launching widespread campaigns to increase awareness of the importance of vaccination and address misinformation.
* Physician advocacy: Encouraging healthcare providers to actively recommend and administer vaccines to their senior patients.
A Collective Effort:
Protecting seniors from preventable diseases requires a collective effort from healthcare providers, policymakers, and communities. By working together, we can empower older adults to take control of their health and live longer, healthier lives.
NewsDirectory3.com will continue to monitor this developing story and provide updates on efforts to increase senior vaccination rates.